InvestorsHub Logo
icon url

couldbebetter

04/19/23 9:08 AM

#407486 RE: ziploc_1 #407484

I thought I read somewhere that at one time PWO was KM's boss.
When PWO became COB I figured it was KM that brought him in
as a favor from past loyalties. Hence, to me it was no surprise that
KM would side with PWO. KM's focus (of course) was mainly on
Europe and he really made a big misstep with Germany, namely
hiring & firing a sales force for that country. AB, the new temp CEO
may have more of a focus on salvaging Europe. Perhaps AD is testing
him to see if has what it takes to be the permanent CEO. My view
remains that only the right BP acquirer will be in a position to optimize
uptake and revenues for AMRN. I wonder what the "real" status of
Vascepa approval for China actually is. Will it ever happen or will some
other company beat out Eddingpharm. Europe, I think, should easily
be a $2 billion plus market for Vascepa if owned by a competent
Eurocentric BP. Hopefully, that is what AD has in mind.